Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan
暂无分享,去创建一个
K. Tsai | Hung-Jung Lin | Chien-Cheng Huang | M. Sheu | Chien-Liang Lin | C. Ho | Hsiao-Hua Liu | Mitsuhiro Koseki
[1] H. Tilg,et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report , 2022, Gut.
[2] H. Takeuchi,et al. Helicobacter pylori Infection and Chronic Immune Thrombocytopenia , 2022, Journal of clinical medicine.
[3] Jaw-Town Lin,et al. Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis , 2022, Helicobacter.
[4] Young Bae Choi,et al. Management of immune thrombocytopenia: 2022 update of Korean experts recommendations , 2022, Blood research.
[5] Qiuyue Huang,et al. Helicobacter pylori Infection in Geriatric Patients: Current Situation and Treatment Regimens , 2021, Frontiers in Medicine.
[6] Jhi-Joung Wang,et al. Real‐time interactive artificial intelligence of things–based prediction for adverse outcomes in adult patients with pneumonia in the emergency department , 2021, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[7] Y. Tomiyama,et al. Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision , 2020, International Journal of Hematology.
[8] Y. Choi,et al. Management of immune thrombocytopenia: Korean experts recommendation in 2017 , 2017, Blood research.
[9] S. Ng,et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.
[10] W. Chey,et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection , 2017, The American Journal of Gastroenterology.
[11] Deng-Chyang Wu,et al. Consensus on the clinical management, screening‐to‐treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale , 2017, Helicobacter.
[12] E. Andrès. What Impact for Sex Difference on Immune Thrombocytopenic Purpura , 2016 .
[13] Deng-Chyang Wu,et al. Diagnosis of Helicobacter pylori infection: Current options and developments. , 2015, World journal of gastroenterology.
[14] J. Jo,et al. Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia , 2015, Annals of Hematology.
[15] C. Sirijerachai,et al. Clinical characteristics and treatment outcomes in patients with Helicobacter pylori-positive chronic immune thrombocytopenic purpura , 2014, Platelets.
[16] M. Douraghi,et al. Seroprevalence of anti-Helicobacter pylori and anti-cytotoxin-associated gene A antibodies among healthy individuals in center of Iran , 2014, Iranian journal of basic medical sciences.
[17] P. Fu,et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy , 2014, Journal of Zhejiang University SCIENCE B.
[18] E. Andrès,et al. Gender-related analysis of the clinical presentation, treatment response and outcome in patients with immune thrombocytopenia. , 2012, Presse medicale.
[19] C. Ruan,et al. Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura , 2009, International journal of hematology.
[20] E. Andrès,et al. Borderline Thrombocytopenia or Mild Idiopathic Thrombocytopenic Purpura? , 2006, PLoS medicine.
[21] Y. Ikeda,et al. Is Eradication Therapy Useful as the First Line of Treatment in Helicobacter pylori-Positive Idiopathic Thrombocytopenic Purpura? Analysis of 207 Eradicated Chronic ITP Cases in Japan , 2005, International journal of hematology.
[22] E. El-Omar,et al. Characteristics of Helicobacter pylori‐Induced Gastritis and the Effect of H. pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura , 2004, Helicobacter.
[23] Y. Oka,et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori‐associated chronic idiopathic thrombocytopenic purpura , 2004, British journal of haematology.
[24] R. Mcmillan. Immune thrombocytopenia. , 1983, Clinics in haematology.